Related Experiment Video
Updated: May 27, 2026
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Chronic mania following polioencephalomyelitis-a case report
B Subrahmanya1, H S Narayana, Shivaprakash
1Resident in Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore-560 029, India.
Indian Journal of Psychiatry
|November 8, 2011
Summary
A rare case of chronic mania following polioencephalomyelitis showed significant improvement with lithium therapy. This finding highlights a potential treatment for this uncommon neurological complication.
Area of Science:
- Neurology
- Psychiatry
Background:
- Polioencephalomyelitis is a rare neurological disorder that can lead to various complications.
- Chronic mania is a persistent mood disorder characterized by elevated mood and energy levels.
Purpose of the Study:
- To present a rare case of chronic mania that developed after polioencephalomyelitis.
- To document the efficacy of lithium therapy in managing this specific clinical presentation.
Main Methods:
- Case report detailing the clinical history, symptoms, and treatment of a patient with chronic mania post-polioencephalomyelitis.
- Administration of conventional lithium therapy.
Main Results:
- The patient exhibited a positive and significant response to lithium treatment.
- The chronic mania symptoms were effectively managed by the prescribed therapy.
Conclusions:
- Lithium therapy can be an effective treatment for chronic mania secondary to polioencephalomyelitis.
- This case underscores the importance of considering mood disorders in patients with a history of polioencephalomyelitis and highlights a successful therapeutic approach.
Related Concept Videos
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...